An update on small-molecule anti-VEGF agents, anti-angiopoietin-2 antibodies, topical drops and port delivery.
A deep dive into what clinical trials report on the efficacy of corticosteroids for retinal disorders.
Acthar gel re-emerges, suprachoroidal triamcinolone acetonide emerges.
Treatment requires patience and a nuanced approach
Catching up with the rapid evolution of technology and techniques used in today’s cataract surgery.